How to transfer my Mounjaro prescription to Pennsylvania

If you’ve been researching weight loss options, you’ve likely encountered GLP-1 medications like Wegovy, Ozempic, and Mounjaro. These injectable medications have transformed obesity treatment, and many people wonder: Can I actually get these medications through telehealth—without visiting a doctor’s office?

The short answer is yes—but there are important details you need to know.

In this comprehensive guide, we’ll walk you through everything about getting weight loss medications via telehealth, from federal and state regulations to what you can realistically expect during the process. Whether you’re exploring telehealth for the first time or comparing your options, this article will help you make an informed decision about your weight loss journey.

Understanding the Legal Landscape: Federal Rules on Telehealth Prescribing

The Good News: GLP-1 Medications Are Telehealth-Friendly

Here’s what matters most: Wegovy, Ozempic, and Mounjaro are not controlled substances under federal law. This is crucial because it means the strict DEA regulations that require in-person exams for medications like Adderall or opioids do not apply to these weight loss drugs.

The Ryan Haight Act—a federal law that typically mandates an initial in-person visit before prescribing controlled medications via telehealth—simply doesn’t restrict GLP-1 prescriptions. From a federal standpoint, a licensed healthcare provider can evaluate you through a video consultation and send your prescription electronically to a pharmacy.

What About COVID-Era Telehealth Rules?

During the pandemic, the DEA temporarily relaxed prescribing rules for controlled substances, allowing doctors to prescribe medications like ADHD stimulants via telehealth without an in-person visit. As of December 2024, these flexibilities have been extended through December 31, 2025.

While this doesn’t directly affect non-controlled medications like Wegovy, it demonstrates the broader acceptance of telehealth prescribing across healthcare. The DEA is working on permanent regulations, and the trend is clearly toward expanded—not restricted—telehealth access.

Bottom line: Federal law fully supports telehealth prescribing of GLP-1 weight loss medications, making online access straightforward from a regulatory perspective.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

State-by-State Requirements: What You Need to Know

While federal law gives the green light, state regulations add another layer of requirements. The good news? No state outright bans telehealth for these medications. However, some states impose specific conditions.

States Requiring an Initial In-Person Visit

A handful of states mandate that patients have at least one in-person examination before or shortly after starting telehealth weight loss treatment:

• Arkansas: Must establish the patient-provider relationship with an initial in-person encounter
• Delaware: Requires an initial physical exam before telehealth prescribing
• Georgia: In-person exam required before prescribing weight loss medications
• Mississippi: Initial in-person evaluation mandated for weight management therapy
• New Jersey: Comprehensive in-person exam including labs required at start
• North Dakota: Initial hands-on evaluation expected
• South Carolina: First exam must be completed in person
• Texas: Generally expects an initial in-person assessment for weight loss prescriptions
• Virginia: Requires physical exam, lab work, and treatment plan documentation initially

If you live in one of these states, reputable telehealth providers will either connect you with a local clinic for your initial visit or guide you on how to complete this requirement before beginning your telehealth treatment.

States with Full Telehealth Access

Many states allow you to start and continue your entire weight loss treatment via telehealth without any in-person requirement:

• California
• Connecticut (with behavioral counseling requirement)
• Illinois
• New York
• Pennsylvania
• Washington

These states recognize that telehealth consultations, when done properly with thorough medical history and ongoing monitoring, meet the standard of care for prescribing weight loss medications.

Special State Requirements to Watch

Some states have unique rules beyond the in-person visit question:

Florida: Requires that patients have a BMI ≥30 and must be seen (in-person or via telehealth) at least once every 3 months during treatment. This ensures regular monitoring and prevents ‘prescribe and forget’ situations.

Connecticut: Mandates that obesity treatment include behavioral counseling and a diet/exercise plan alongside medication—not just a prescription alone.

Virginia: Requires a follow-up visit within 30 days of starting therapy to assess tolerance and adjust the treatment plan.

These requirements actually align with best practices—reputable telehealth providers follow these standards regardless of state law because they prioritize patient safety and treatment success.

Who Can Prescribe? Understanding Provider Credentials

When you schedule a telehealth consultation for weight loss medication, you might see a physician (MD or DO), nurse practitioner (NP), or physician assistant (PA). All three types of providers can legally prescribe GLP-1 medications—but their level of independence varies by state.

Physicians (MDs and DOs)

Medical doctors and doctors of osteopathic medicine can prescribe these medications in every state via telehealth, assuming they hold a valid medical license in the state where you’re located. This is straightforward and universally accepted.

Nurse Practitioners (NPs)

Nurse practitioners are increasingly taking the lead in obesity care, and their prescribing authority has expanded significantly:

• 34 states plus DC now allow NPs to practice with full independence—no physician supervision required. These include Arizona, California, Colorado, Connecticut, Hawaii, Idaho, Iowa, Maine, Maryland, Massachusetts, Michigan, Minnesota, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Dakota, Oregon, Rhode Island, South Dakota, Utah, Vermont, Virginia, Washington, and Wyoming, plus Washington D.C.

• Other states require collaborative agreements: In states like Florida, Georgia, Illinois, Pennsylvania, and Texas, NPs must have a supervisory or collaborative relationship with a physician. This doesn’t mean they can’t prescribe GLP-1 medications—they absolutely can—but there’s physician oversight involved.

• Recent expansions: Georgia passed legislation in 2024 allowing NPs and PAs to prescribe even Schedule II controlled substances (like Adderall) with physician delegation. While this doesn’t directly affect non-controlled GLP-1 drugs, it shows the trend toward recognizing NPs’ clinical expertise.

Physician Assistants (PAs)

PAs can prescribe weight loss medications in all 50 states, though they typically work under a physician’s license and supervision. The level of autonomy varies—some states allow PAs significant independence, while others require closer oversight. Regardless, a PA consultation for Wegovy or Mounjaro is completely legitimate and legal.

What this means for you: When you use a telehealth service like Klarity Health, you may be matched with an NP, PA, or physician based on availability and your state’s regulations. All are qualified to evaluate your weight loss needs and prescribe appropriately—the key is that they’re licensed in your state and following proper clinical protocols.

The Telehealth Prescription Process: What to Expect

Understanding what happens during a telehealth weight loss consultation helps you prepare and know what’s legitimate versus what’s a red flag.

Step 1: Comprehensive Medical Intake

Before your video consultation, you’ll complete a detailed health questionnaire covering:

• Current and past medical conditions (especially thyroid disorders, gastrointestinal issues, diabetes, heart disease)
• Family history (particularly medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2—critical contraindications)
• Current medications and supplements
• Allergies
• Previous weight loss attempts (diet, exercise programs, other medications)
• Current height and weight (to calculate BMI)
• Mental health history (depression, eating disorders)
• Pregnancy status and plans (GLP-1 medications must be stopped before pregnancy)

Legitimate telehealth providers take this step seriously. If a service promises you a prescription with just a few basic questions, that’s a major red flag.

Step 2: Live Video Consultation

You’ll meet with a licensed provider via secure video. This isn’t a quick rubber-stamp appointment—expect a thorough discussion covering:

• Why you want to lose weight and what you’ve already tried
• Your health goals and realistic expectations
• How GLP-1 medications work (mechanism of action, what to expect)
• Common side effects like nausea, vomiting, diarrhea, and constipation—and how to manage them
• Serious but rare risks including pancreatitis, gallbladder problems, and the thyroid cancer warning
• The importance of lifestyle changes alongside medication
• Treatment plan including starting dose, titration schedule, and follow-up timing

The provider will assess whether you meet clinical criteria:

• BMI ≥30 (obesity), or
• BMI ≥27 with at least one weight-related health condition (like type 2 diabetes, high blood pressure, high cholesterol, or sleep apnea)

If you don’t meet these criteria, a responsible provider will recommend lifestyle modifications first rather than prescribing medication.

Step 3: Prescription and Pharmacy

If you’re a good candidate, the provider will send an electronic prescription to your preferred pharmacy. Because these are non-controlled medications, there’s no special DEA paperwork or restrictions.

Starting dose: You’ll typically begin with a low dose to minimize side effects. For example:

• Wegovy: 0.25 mg weekly for 4 weeks
• Ozempic: 0.25 mg weekly for 4 weeks
• Mounjaro: 2.5 mg weekly for 4 weeks

The dose gradually increases over several months as your body adjusts.

Cost considerations: These medications are expensive—often $900-$1,500 per month without insurance. Many telehealth providers like Klarity Health work with both insurance plans and cash-pay options, and can help you navigate manufacturer savings programs or patient assistance. Some states’ Medicaid programs now cover these medications for obesity, and private insurance coverage is expanding (though still inconsistent).

Step 4: Ongoing Monitoring and Follow-Up

This is where quality telehealth providers distinguish themselves. Weight loss medication isn’t ‘prescribe and forget’—it requires regular follow-up:

• First follow-up: Usually 2-4 weeks after starting, to assess tolerance and side effects
• Subsequent visits: Every 1-3 months to monitor progress, adjust dosing, review labs, and ensure safety

Some states legally mandate this follow-up schedule (like Florida’s 3-month requirement), but all responsible providers do it regardless.

During follow-ups, expect discussion of:

• Weight changes (healthy loss is typically 1-2% per week initially, building to 5-15% total over several months)
• Side effects and management strategies
• Medication adherence (are you remembering your weekly injection?)
• Diet and exercise progress
• Lab work if needed (metabolic panel, A1C, lipid panel)

Medication Comparison: Wegovy vs. Ozempic vs. Mounjaro

Understanding the differences helps you have an informed conversation with your telehealth provider.

All three are self-injected once weekly using pre-filled pens. Your provider or pharmacist will teach you injection technique—it’s subcutaneous (under the skin), typically in the abdomen, thigh, or upper arm.

None of these are controlled substances, so there are no DEA restrictions, prescription limits, or special monitoring databases.

Debunking Common Misconceptions

Myth 1: ‘Anyone Can Get Ozempic Online for Quick Weight Loss’

Reality: Legitimate telehealth providers screen carefully. If you don’t meet BMI criteria or have contraindications, you won’t—and shouldn’t—get a prescription. These are powerful medications for people with clinical obesity or significant weight-related health risks, not cosmetic quick fixes for someone looking to drop 10 pounds before vacation.

Myth 2: ‘Telehealth Weight Loss Is Just Pill Mills’

Reality: The term ‘pill mill’ refers to unethical clinics that hand out controlled substances like opioids or stimulant diet pills without proper evaluation. GLP-1 medications aren’t controlled substances, and reputable telehealth providers follow rigorous clinical protocols—often exceeding what you’d get in a rushed 15-minute office visit. Quality telehealth platforms employ board-certified providers, use evidence-based treatment protocols, and maintain ongoing patient relationships.

Myth 3: ‘You Can Get Cheaper Compounded Versions Online’

Reality: The FDA effectively banned most compounded semaglutide for weight loss in May 2025, after declaring the shortage over. Some telehealth companies that offered compounded versions had to shut down those programs. While compounding pharmacies can still prepare semaglutide in very limited circumstances (like for patients with allergies to commercial formulation ingredients), the days of widely available cheap ‘compounded Ozempic’ are over. Stick with FDA-approved brand-name medications dispensed through licensed pharmacies.

Myth 4: ‘Telehealth Means No Real Doctor-Patient Relationship’

Reality: The ‘doctor-patient relationship’ is a legal and ethical concept about appropriate care, not physical proximity. Courts and medical boards have affirmed that telehealth consultations—when done with proper evaluation, informed consent, documentation, and follow-up—constitute a valid patient-provider relationship. You’ll actually spend more time discussing your health in a telehealth video visit than in many rushed office appointments.

Myth 5: ‘My State Doesn’t Allow Telehealth Prescribing’

Reality: Every U.S. state allows telehealth prescribing for non-controlled medications. Some require an initial in-person visit (see our state table), but none ban telehealth weight loss treatment outright. If a provider tells you they can’t treat you, it’s likely because they’re not licensed in your state—not because telehealth is illegal there.

Red Flags: How to Spot Illegitimate Services

The popularity of Wegovy and Ozempic has unfortunately attracted some questionable operators. Protect yourself by watching for these warning signs:

🚩 No real evaluation: Any service that ‘guarantees’ a prescription before speaking with you, or that uses only a text-based questionnaire with no video consult

🚩 Compounded medications: Offers ‘compounded semaglutide’ or ‘generic Wegovy’ (there is no legal generic; compounding is now largely banned by FDA)

🚩 Overseas/unlicensed pharmacies: Ships medication from outside the U.S. or from pharmacies that aren’t properly licensed

🚩 No follow-up: Prescribes for 6-12 months upfront with no scheduled check-ins or monitoring

🚩 Unclear provider credentials: Doesn’t clearly state who your prescriber is or what state they’re licensed in

🚩 Too good to be true pricing: Offers brand-name Wegovy for $100/month (it costs pharmacies more than that to buy wholesale)

🚩 No informed consent: Doesn’t discuss risks, side effects, or alternatives—just fast-tracks to prescription

🚩 Pressure tactics: Uses scarcity language (‘limited supply—order now!’) or celebrity endorsements without medical context

What to look for instead: Platforms like Klarity Health that clearly display provider credentials, require comprehensive intake and video consultation, prescribe only FDA-approved medications through legitimate pharmacies, schedule regular follow-ups, and provide transparent pricing for both the consultation and the medication.

Insurance, Cost, and Klarity Health’s Approach

Let’s be honest—cost is a major factor for most people considering GLP-1 medications.

Insurance Coverage

Coverage is improving but still inconsistent:

• Medicare: Traditional Medicare does not cover weight loss medications (though some Medicare Advantage plans do). However, Congress is considering changing this, and coverage may expand in 2026-2027.

• Private insurance: Many commercial plans now cover Wegovy/Zepbound for obesity, though criteria vary. You typically need to meet BMI thresholds and try lifestyle modification first. Prior authorization is almost always required.

• Medicaid: About 15 states now cover GLP-1 medications for obesity through Medicaid, with more expected to add coverage.

• Off-label Ozempic: Insurance will cover Ozempic if you have type 2 diabetes, but usually not for weight loss alone (since Wegovy is the FDA-approved obesity drug).

Cash-Pay Options

For those without coverage:

• Manufacturer savings cards: Novo Nordisk (Wegovy/Ozempic) and Eli Lilly (Mounjaro/Zepbound) offer savings programs that can reduce cost to as low as $25-$550/month for eligible patients

• Patient assistance programs: Free medication for those who qualify based on income

• Telehealth platforms with negotiated pricing: Some telehealth services negotiate special pricing with pharmacies or offer subscription models

How Klarity Health Helps

Klarity Health offers a transparent, accessible approach to weight loss treatment:

Flexible payment options: Klarity accepts major insurance plans and offers affordable cash-pay rates, with clear pricing upfront—no surprise bills.

Provider availability: With providers licensed in multiple states, Klarity can serve patients across most of the U.S. without long wait times. Evening and weekend appointments make care accessible around your schedule.

Comprehensive care: Klarity’s approach includes thorough evaluation, medication management, lifestyle counseling, and ongoing support—not just a prescription mill.

Cost navigation: Klarity’s team helps you explore manufacturer savings programs, insurance coverage options, and alternative medications if cost is a barrier.

Continuity of care: Your Klarity provider stays with you throughout treatment, adjusting your plan as needed and being available when questions arise.

If you’re finding that traditional weight loss approaches aren’t working and you meet the medical criteria, Klarity Health’s telehealth platform offers a legitimate, safe, and convenient path to accessing these medications while prioritizing your health and wellbeing.

What Happens After You Start Treatment

Starting a GLP-1 medication is just the beginning of your weight loss journey. Here’s what the next several months typically look like:

Weeks 1-4: Adjustment Phase

What you’ll experience:

• Mild to moderate nausea (most common side effect)
• Reduced appetite—you’ll feel full faster
• Possible constipation or diarrhea as your digestion adjusts
• Some fatigue as your body adapts

Management strategies:

• Eat smaller, more frequent meals
• Avoid fatty, fried, or very sweet foods that worsen nausea
• Stay hydrated
• Increase fiber gradually to help with constipation
• Report severe symptoms to your provider immediately

Months 2-4: Titration and Early Results

Your dose will gradually increase (usually every 4 weeks) as tolerated. Weight loss accelerates during this phase:

• Expected loss: 5-10% of starting weight by month 3-4
• Side effects: Usually improve as your body adjusts to each new dose
• Lifestyle focus: Continue building healthy eating patterns and increasing physical activity

Months 4-12: Sustained Weight Loss

You’ll reach your maintenance dose and see continued steady weight loss:

• Expected loss: 10-15% (or more) by 6-12 months
• Metabolic improvements: Blood pressure, cholesterol, and blood sugar often improve significantly
• Habit formation: You’re developing sustainable lifestyle changes that will help long-term

Long-Term Maintenance

GLP-1 medications are typically long-term treatments. Many people continue them indefinitely to maintain weight loss, similar to how someone with high blood pressure takes medication ongoing. Your provider will discuss:

• Duration of treatment: How long you’ll likely stay on medication
• What happens if you stop: Weight regain is common when stopping (this is a chronic condition)
• Adjusting doses: Some people can reduce to a lower maintenance dose
• Cost and coverage: Planning for ongoing treatment expenses

The Future of Telehealth Weight Loss Treatment

The regulatory landscape continues to evolve in favor of expanded access:

Federal developments:

• The DEA’s temporary telehealth flexibilities (mainly affecting controlled substances) are likely to become permanent in some form, signaling broader acceptance of telemedicine prescribing
• The TREATS Act, if passed, would permanently authorize telehealth prescribing for certain medications and establish clear federal standards
• Congress is considering Medicare coverage expansion for obesity medications, which would dramatically increase access for seniors

State trends:

• More states are granting nurse practitioners full practice authority, expanding the provider pool for telehealth obesity care
• Interstate medical licensure compacts are making it easier for providers to treat patients across state lines
• State-specific telehealth regulations are being standardized and simplified

Technology advances:

• Integration with at-home testing (fingerstick labs sent via mail)
• Continuous glucose monitors to track metabolic response
• App-based weight tracking and lifestyle coaching alongside medication
• AI-assisted monitoring for early detection of side effects

Clinical developments:

• New GLP-1 and dual-agonist medications in development with better side effect profiles
• Oral versions (no injection) coming to market
• Combination therapies for even greater effectiveness

The bottom line: Telehealth access to weight loss medications will continue to expand and improve, making safe, effective treatment more convenient and affordable.

Your Next Steps: Is Telehealth Weight Loss Right for You?

Consider telehealth weight loss treatment if:

✅ You meet BMI criteria (≥30, or ≥27 with weight-related health conditions)

✅ You’ve tried diet and exercise but struggled to lose weight or keep it off

✅ You have no contraindications (thyroid cancer history, pregnancy, etc.)

✅ You’re committed to lifestyle changes alongside medication

✅ You want the convenience of virtual appointments with qualified providers

✅ You need flexibility due to work schedule, childcare, or limited local specialists

✅ You prefer a transparent, patient-centered approach with clear pricing

It may not be the right fit if:

• You’re looking for a quick cosmetic fix rather than treating clinical obesity
• You’re not willing to commit to follow-up appointments and monitoring
• You have active gallbladder disease, pancreatitis, or other serious contraindications
• You’re pregnant or planning pregnancy in the next 6-12 months

Take the First Step with Klarity Health

If you’re ready to explore whether GLP-1 weight loss medications are right for you, Klarity Health makes it easy to get started:

Simple process:

1. Complete a brief online intake (10-15 minutes)
2. Schedule a video consultation with a licensed provider in your state
3. Discuss your health history, goals, and treatment options
4. Get your prescription sent to your preferred pharmacy if appropriate
5. Access ongoing support and monitoring throughout your journey

What sets Klarity apart:

• Board-certified providers with obesity medicine expertise
• Same-day or next-day appointments available
• Accepts insurance and offers transparent cash-pay rates
• Comprehensive treatment plans—not just prescriptions
• Available in most U.S. states with provider availability when you need it

Weight loss is a journey, not a destination—and having the right support makes all the difference. With proper telehealth care, you can access effective medical treatment from the comfort of home while building the lifestyle habits that create lasting change.

Ready to learn more? Visit Klarity Health to schedule your consultation and take the first step toward sustainable weight loss with expert medical support.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any weight loss medication or treatment program. Individual results may vary, and not all patients are appropriate candidates for GLP-1 medications.

References

1. DEA Announcement (Nov 2024) – ‘DEA and HHS Extend Telemedicine Flexibilities through 2025’ – www.dea.gov

2. Axios News – ‘COVID-era telehealth prescribing extended’ – www.axios.com

3. McDermott Will & Emery Legal Analysis – ‘DEA Extends Telemedicine Flexibilities for Controlled Substance Prescribing’ – www.mwe.com

4. Goodwin Procter Client Alert – ‘The Changing Regulatory and Reimbursement Landscape for Weight Loss Drugs’ – www.goodwinlaw.com

5. Reuters Healthcare News – ‘Hims & Hers to cut 4% of workforce amid ban on weight loss drug copies’ – www.reuters.com

Verified as of: December 17, 2025. Federal and state telehealth regulations are subject to change. Readers should verify current rules in their state before making treatment decisions.

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid